Longevity cosmeceuticals represent the next major evolution in skincare, shifting focus from superficial anti-aging effects to biologically grounded interventions.

Scientific rigor is becoming essential as consumers and regulators expect biomarker-driven proof, mechanistic validation, and long-term efficacy. Advances in genomics, proteomics, and epigenetics now enable credible measurement of biological age reversal in skin.

This review looks at how together these developments position longevity cosmeceuticals to redefine innovation, claims substantiation, and premium market differentiation in the beauty industry.